Meanwhile, 63 percent of adults ages 50 to 80 who are overweight expressed interest in taking a weight loss medication, according to research from the National Poll on Healthy Aging
That example matters for food and packaging because it shows how a health intervention can create second-order demand effects
GLP-1 medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, are approved by the FDA for their specific indications after rigorous testing and clinical trials
An equivalent procedure was used for a GWAS of side effect phenotypes
Bert said that multiple studies show that there is potential for an increase of NAION
But here it is, and youre looking at a VA population, which is usually an older, sicker population, and youre seeing actually potentially decreased risks, of aspiration pneumonia, Butsch said